708
Participants
Start Date
July 31, 2009
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Insulin Glargine (HOE901) [Lantus]
100 Units/ml solution for injection in a pre-filled pen SoloStar® (3 ml)
Glimepiride
tablets of 1 and 2 mg
human insulin [NPH]
100 IU/ml suspension for injection in a prefilled pen OptiSet® (3 ml)
Investigational Site Number 756001, Geneva
Investigational Site Number 784-001, Dubai
Investigational Site Number 203004, Prague
Investigational Site Number 203005, Prague
Investigational Site Number 764004, Bangkok
Investigational Site Number 764001, Bangkok
Investigational Site Number 250-003, Narbonne
Investigational Site Number 764005, Pathum Thani
Investigational Site Number 250-002, Aix-en-Provence
Investigational Site Number 203007, Prague
Investigational Site Number 752001, Stockholm
Investigational Site Number 752002, Malmo
Investigational Site Number 752004, Lund
Investigational Site Number 203003, Beroun
Investigational Site Number 764006, Nakhonratchasima
Investigational Site Number 250-005, Bordeaux
Investigational Site Number 203008, České Budějovice
Investigational Site Number 203011, České Budějovice
Investigational Site Number 203009, Moravský Písek
Investigational Site Number 764003, Khon Kaen
Investigational Site Number 484009, Pachuca
Investigational Site Number 484003, Guadalajara
Investigational Site Number 484005, Guadalajara
Investigational Site Number 203010, Liberec
Investigational Site Number 764002, Chiang Mai
Investigational Site Number 752003, Skene
Investigational Site Number 203001, Chrudim III
Investigational Site Number 250-004, Jarny
Investigational Site Number 484001, Monterrey
Investigational Site Number 250-006, Strasbourg
Investigational Site Number 203006, Hodonín
Investigational Site Number 484002, Puebla City
Investigational Site Number 203002, Hranice I - Mesto
Investigational Site Number 703003, Bratislava
Investigational Site Number 703007, Bratislava
Investigational Site Number 703008, Levice
Investigational Site Number 703005, Banská Bystrica
Investigational Site Number 643-004, St-Ptetersburg
Investigational Site Number 643-002, Saint Petersburg
Investigational Site Number 643-007, Tyumen
Investigational Site Number 076-007, Rio de Janeiro
Investigational Site Number 076-001, Fortaleza
Investigational Site Number 076-006, Fortaleza
Investigational Site Number 076-005, Porto Alegre
Investigational Site Number 076-004, São Paulo
Investigational Site Number 076-003, São Paulo
Investigational Site Number 076-002, São Paulo
Investigational Site Number 818001, Menoufiya
Investigational Site Number 414001, Kuwait City
Investigational Site Number 642001, Bucharest
Investigational Site Number 642002, Bucharest
Investigational Site Number 642009, Cluj-Napoca
Investigational Site Number 642003, Craiova
Investigational Site Number 642005, Iași
Investigational Site Number 642010, Oradea
Investigational Site Number 642011, Oradea
Investigational Site Number 642007, Ploieşti
Investigational Site Number 642004, Reşiţa
Investigational Site Number 642008, Târgu Mureş
Investigational Site Number 642012, Timișoara
Investigational Site Number 643-001, Moscow
Investigational Site Number 643-003, Saint Petersburg
Investigational Site Number 643-006, Samara
Investigational Site Number 643-005, Saratov
Investigational Site Number 410005, Daegu
Investigational Site Number 410003, Seoul
Investigational Site Number 410004, Seoul
Investigational Site Number 250-001, Antibes
Investigational Site Number 380001, Perugia
Investigational Site Number 484008, Pachuca
Investigational Site Number 528006, Almelo
Investigational Site Number 528005, Apeldoorn
Investigational Site Number 528001, Beek
Investigational Site Number 528002, Hoogeveen
Investigational Site Number 528004, Hoogezand
Investigational Site Number 528003, Rotterdam
Investigational Site Number 616004, Gdansk
Investigational Site Number 616003, Krakow
Investigational Site Number 616002, Lublin
Investigational Site Number 616001, Zabrze
Investigational Site Number 703004, Košice
Investigational Site Number 703006, Košice
Investigational Site Number 703002, Košice
Investigational Site Number 703001, Martin
Investigational Site Number 410002, Gyeonggi-do
Investigational Site Number 410006, Incheon
Investigational Site Number 410001, Seoul
Lead Sponsor
Sanofi
INDUSTRY